ConductScience.org, home

Gene · 80329

ULBP1: UL16 binding protein 1

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ULBP1: UL16 binding protein 1. Genes, record 80329. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/80329

On this page

Gene

Symbol
ULBP1
HGNC
Name
UL16 binding protein 1
HGNC
NCBI Gene ID
80329
NCBI Gene
HGNC ID
HGNC:14893
HGNC
Ensembl
ENSG00000111981
NCBI Gene
Aliases
N2DL-1, NKG2DL1, RAET1I
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9BZM6UL16-binding protein 12440Ensembl, GeneID, HGNC

Source UniProt

Patents63

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1469268Q9BZM6Espacenet
JP 2026004568 A2026-01-1469269Q9BZM6Espacenet
JP 2026500896 A2026-01-09153Q9BZM6Espacenet
EP 4650780 A22025-11-19747Q9BZM6Espacenet
WO 2025235604 A12025-11-13153Q9BZM6Espacenet
WO 2025235605 A12025-11-13153Q9BZM6Espacenet
WO 2025231174 A12025-11-0625Q9BZM6Espacenet
EP 4641201 A22025-10-29524Q9BZM6Espacenet
JP 2025529142 A2025-09-045181Q9BZM6Espacenet
US 12371689 B22025-07-295181Q9BZM6Espacenet

1 to 10 of 63

See all 63 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants601

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleULBP1 papersNewest fiscal year
P30CA021765Cancer Center Support Grant (CCSG)62025
P30CA016672Cancer Center Support Grant52025
P30CA016056Roswell Park Cancer Center Support Grant42025
R01DK088199Endoplasmic reticulum stress and intestinal inflammation42025
P30AR069655Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)32025
P30CA008748Cancer Center Support Grant32025
P30CA093373Cancer Center Support Grant P3032025
P30DK034854Integrated Epithelial and Muscosal Biology32025
R01DK044319Characterization of Mucosal Lymphocytes32025
R01DK051362Regulation of Mucosal Lymphocytes32025

1 to 10 of 601Source NIH's project files

See all 601 nih grants

Papers1,302

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
ULBP1 is a prognostic biomarker associated with immune suppression in breast cancer.Front Oncol202642718478PubTator, text miningPubMed
KRASG12D inhibition reprograms the tumor-induced immunosuppressive environment and enhances NK cell-mediated antitumor immunity.Sci Adv202642490421PubTator, text miningPubMed
Cerebrospinal Fluid Transcriptional Immune Pathways Linked to Survival in HIV-Associated Tuberculous Meningitis.J Infect Dis202642313402PubTator, text miningPubMed
Increased ULBP1 by doxorubicin sensitizes neuroblastoma to γδT-cell cytotoxicity.J Immunol202642309532PubTator, text miningPubMed
Multi-mechanistic mitochondria-mediated N-methylated YKWYYRGAA-decorated nano-chitosan conjugate carrier for treatment of NRAS-mutant-harbouring lung carcinoma.Carbohydr Polym202642230031PubTator, text miningPubMed
Xylooligosaccharides ameliorate intestinal barrier injury by inhibiting apoptosis, RhoA/ROCK/MLCK signaling and NKG2DLs in intestinal epithelial cells.Food Res Int202642116516PubTator, text miningPubMed
Unraveling the implications of ULBP1 expression from pan-cancer to head and neck squamous cell carcinoma.Sci Rep202642106428PubTator, text miningPubMed
Metformin drives HIF-1α-mediated dual metabolic reprogramming to enhance γδ T cell therapy in triple-negative breast cancer.Cancer Immunol Immunother202641925872PubTator, text miningPubMed
Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy.Ann Hematol202641915070PubTator, text miningPubMed
cGAS/STING-mediated upregulation of NKG2D ligands in LSCs contributes to enhanced sensitivity to NK cells.Front Oncol202641809821PubTator, text miningPubMed

1 to 10 of 1,302

See all 1,302 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/80329

GET https://conductscience.org/api/genes/v1/80329/patents?page=2